S Sundar1, G Agrawal, M Rai, M K Makharia, H W Murray. 1. Kala-Azar Medical Research Centre, Banaras Hindu University, Department of Medicine, Institute of Medical Sciences, Varanasi-211005, India. shyams_vns@satyam.net.in
Abstract
OBJECTIVE: To test short course, low dose liposomal amphotericin B as single or daily infusion treatment in Indian visceral leishmaniasis (kala-azar). DESIGN: Randomised, open label study. SETTING:Inpatient unit for leishmaniasis in Bihar, India. PARTICIPANTS: 91 adults and children with splenic aspirate positive for infection. INTERVENTIONS: Total dose of 5 mg/kg of liposomal amphotericin B given as a single infusion (n=46) or as once daily infusions of 1 mg/kg for five days (n=45). MAIN OUTCOME MEASURES: Clinical and parasitological cure assessed 14 days after treatment and long term definitive cure (healthy, no relapse) at six months. RESULTS: All but one person in each group had an initial apparent cure. During six months of follow up, three patients in the single dose group and two in the five dose group relapsed. Complete response (definitive cure) was therefore achieved in 84 of 91 subjects (92%): 42 of 46 patients in the single dose group (91%, 95% confidence interval 79% to 98%) and 42 of 45 in the five dose group (93%, 82% to 99%). Response rates in the two groups were not significantly different. CONCLUSION:Low dose liposomal amphotericin B (5 mg/kg), given either as a five day course or as a single infusion, seems to be effective for visceral leishmaniasis and warrants further testing.
RCT Entities:
OBJECTIVE: To test short course, low dose liposomal amphotericin B as single or daily infusion treatment in Indian visceral leishmaniasis (kala-azar). DESIGN: Randomised, open label study. SETTING: Inpatient unit for leishmaniasis in Bihar, India. PARTICIPANTS: 91 adults and children with splenic aspirate positive for infection. INTERVENTIONS: Total dose of 5 mg/kg of liposomal amphotericin B given as a single infusion (n=46) or as once daily infusions of 1 mg/kg for five days (n=45). MAIN OUTCOME MEASURES: Clinical and parasitological cure assessed 14 days after treatment and long term definitive cure (healthy, no relapse) at six months. RESULTS: All but one person in each group had an initial apparent cure. During six months of follow up, three patients in the single dose group and two in the five dose group relapsed. Complete response (definitive cure) was therefore achieved in 84 of 91 subjects (92%): 42 of 46 patients in the single dose group (91%, 95% confidence interval 79% to 98%) and 42 of 45 in the five dose group (93%, 82% to 99%). Response rates in the two groups were not significantly different. CONCLUSION: Low dose liposomal amphotericin B (5 mg/kg), given either as a five day course or as a single infusion, seems to be effective for visceral leishmaniasis and warrants further testing.
Authors: S Sundar; D K More; M K Singh; V P Singh; S Sharma; A Makharia; P C Kumar; H W Murray Journal: Clin Infect Dis Date: 2000-10 Impact factor: 9.079
Authors: J D Berman; R Badaro; C P Thakur; K M Wasunna; K Behbehani; R Davidson; F Kuzoe; L Pang; K Weerasuriya; A D Bryceson Journal: Bull World Health Organ Date: 1998 Impact factor: 9.408
Authors: L di Martino; R N Davidson; R Giacchino; S Scotti; F Raimondi; E Castagnola; L Tasso; A Cascio; L Gradoni; M Gramiccia; M Pettoello-Mantovani; A D Bryceson Journal: J Pediatr Date: 1997-08 Impact factor: 4.406
Authors: R N Davidson; L di Martino; L Gradoni; R Giacchino; G B Gaeta; R Pempinello; S Scotti; A Cascio; E Castagnola; A Maisto; M Gramiccia; D di Caprio; R J Wilkinson; A D Bryceson Journal: Clin Infect Dis Date: 1996-06 Impact factor: 9.079
Authors: R Dietze; S M Fagundes; E F Brito; E P Milan; T F Feitosa; F A Suassuna; G Fonschiffrey; G Ksionski; J Dember Journal: Trans R Soc Trop Med Hyg Date: 1995 May-Jun Impact factor: 2.184
Authors: Prabhat K Sinha; Paul Roddy; Pedro Pablo Palma; Alice Kociejowski; María Angeles Lima; Vidya Nand Rabi Das; Jitendra Gupta; Nawin Kumar; Gaurab Mitra; Jean-François Saint-Sauveur; Siju Seena; Manica Balasegaram; Fernando Parreño; Krishna Pandey Journal: Am J Trop Med Hyg Date: 2010-08 Impact factor: 2.345
Authors: Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo Journal: Drug Dev Res Date: 2011-09 Impact factor: 4.360
Authors: Ada Rs Diehl; Rodrigo P Dos Santos; Ricardo Zimmerman; Letícia P Luz; Tanara Weiss; Pedro Jacobson; Luciano Z Goldani Journal: Can J Infect Dis Med Microbiol Date: 2004-07 Impact factor: 2.471